BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21259243)

  • 1. Using detection of survivin-expressing circulating tumor cells in peripheral blood to predict tumor recurrence following curative resection of gastric cancer.
    Cao W; Yang W; Li H; Lou G; Jiang J; Geng M; Xi W; Ren R; Qu Q; Jin X; Zhu Y; Jin Y
    J Surg Oncol; 2011 Feb; 103(2):110-5. PubMed ID: 21259243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse.
    Yie SM; Lou B; Ye SR; Cao M; He X; Li P; Hu K; Rao L; Wu SM; Xiao HB; Gao E
    Ann Surg Oncol; 2008 Nov; 15(11):3073-82. PubMed ID: 18670822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR.
    Koga T; Tokunaga E; Sumiyoshi Y; Oki E; Oda S; Takahashi I; Kakeji Y; Baba H; Maehara Y
    Hepatogastroenterology; 2008; 55(84):1131-5. PubMed ID: 18705345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of detecting survivin-expressing circulating cancer cells in patients with non-small cell lung cancer.
    Yie SM; Lou B; Ye SR; He X; Cao M; Xie K; Ye NY; Lin R; Wu SM; Xiao HB; Gao E
    Lung Cancer; 2009 Feb; 63(2):284-90. PubMed ID: 18606477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disseminated tumor cells in the blood of patients with gastric cancer are an independent predictive marker of poor prognosis.
    Illert B; Fein M; Otto C; Cording F; Stehle D; Thiede A; Timmermann W
    Scand J Gastroenterol; 2005 Jul; 40(7):843-9. PubMed ID: 16109661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the presence of circulating tumor cells in the venous drainage of curative colorectal cancer resections determine prognosis? A meta-analysis.
    Katsuno H; Zacharakis E; Aziz O; Rao C; Deeba S; Paraskeva P; Ziprin P; Athanasiou T; Darzi A
    Ann Surg Oncol; 2008 Nov; 15(11):3083-91. PubMed ID: 18787906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-21 is a new marker of circulating tumor cells in gastric cancer patients.
    Zheng Y; Cui L; Sun W; Zhou H; Yuan X; Huo M; Chen J; Lou Y; Guo J
    Cancer Biomark; 2011-2012; 10(2):71-7. PubMed ID: 22430134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of circulating cancer cells after a gastrectomy for gastric cancer.
    Ikeguchi M; Kaibara N
    Surg Today; 2005; 35(6):436-41. PubMed ID: 15912289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of circulating tumor cells in peripheral blood from patients with gastric cancer.
    Uenosono Y; Arigami T; Kozono T; Yanagita S; Hagihara T; Haraguchi N; Matsushita D; Hirata M; Arima H; Funasako Y; Kijima Y; Nakajo A; Okumura H; Ishigami S; Hokita S; Ueno S; Natsugoe S
    Cancer; 2013 Nov; 119(22):3984-91. PubMed ID: 23963829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early prediction of tumor recurrence after curative resection of gastric carcinoma by measuring soluble E-cadherin.
    Chan AO; Chu KM; Lam SK; Cheung KL; Law S; Kwok KF; Wong WM; Yuen MF; Wong BC
    Cancer; 2005 Aug; 104(4):740-6. PubMed ID: 15991243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the presence of circulating hepatocellular carcinoma cells indicate a risk of recurrence after resection?
    Jeng KS; Sheen IS; Tsai YC
    Am J Gastroenterol; 2004 Aug; 99(8):1503-9. PubMed ID: 15307868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of circulating tumor cells in blood by molecular detection and tumor markers in esophageal cancer.
    Nakashima S; Natsugoe S; Matsumoto M; Miyazono F; Nakajo A; Uchikura K; Tokuda K; Ishigami S; Baba M; Takao S; Aikou T
    Surgery; 2003 Feb; 133(2):162-9. PubMed ID: 12605177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGF and cortactin expression are independent predictors of tumor recurrence following curative resection of gastric cancer.
    Wang X; Cao W; Mo M; Wang W; Wu H; Wang J
    J Surg Oncol; 2010 Sep; 102(4):325-30. PubMed ID: 20589712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
    Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
    Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of early-stage colorectal cancer patients at risk of relapse post-resection by immunobead reverse transcription-PCR analysis of peritoneal lavage fluid for malignant cells.
    Lloyd JM; McIver CM; Stephenson SA; Hewett PJ; Rieger N; Hardingham JE
    Clin Cancer Res; 2006 Jan; 12(2):417-23. PubMed ID: 16428481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of occult HER2 mRNA-positive tumor cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic relevance.
    Apostolaki S; Perraki M; Kallergi G; Kafousi M; Papadopoulos S; Kotsakis A; Pallis A; Xenidis N; Kalmanti L; Kalbakis K; Agelaki S; Kalykaki A; Stournaras C; Stathopoulos E; Georgoulias V; Mavroudis D
    Breast Cancer Res Treat; 2009 Oct; 117(3):525-34. PubMed ID: 19016323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinoembryonic antigen messenger RNA expression in blood can predict relapse in gastric cancer.
    Ishigami S; Sakamoto A; Uenosono Y; Nakajo A; Okumura H; Matsumoto M; Setoyama T; Arigami T; Uchikado Y; Arima H; Natsugoe S; Aikou T
    J Surg Res; 2008 Aug; 148(2):205-9. PubMed ID: 17936797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence.
    Lai IR; Lee WJ; Huang MT; Lin HH
    Hepatogastroenterology; 2002; 49(46):1157-60. PubMed ID: 12143226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent presence of postoperative circulating tumor cells is a poor prognostic factor for patients with stage I-III colorectal cancer after curative resection.
    Uen YH; Lu CY; Tsai HL; Yu FJ; Huang MY; Cheng TL; Lin SR; Wang JY
    Ann Surg Oncol; 2008 Aug; 15(8):2120-8. PubMed ID: 18481151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of prognostic influence of circulating tumor cells in peripheral blood of patients with colorectal cancer.
    Bessa X; Elizalde JI; Boix L; Piñol V; Lacy AM; Saló J; Piqué JM; Castells A
    Gastroenterology; 2001 Apr; 120(5):1084-92. PubMed ID: 11266372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.